{Reference Type}: Journal Article
{Title}: Mycoplasma genitalium in pregnancy, including specific co-infections, is associated with lower birthweight: A prospective cohort study.
{Author}: Scoullar MJL;Melepia P;Peach E;Fidelis R;Supsup H;Davidson EM;Boeuf P;Bradshaw CS;Fehler G;Hezeri P;Kabiu D;Elijah A;Siba PM;Kennedy EC;Umbers AJ;Robinson LJ;Vallely AJ;Badman SG;Vallely LM;Fowkes FJI;Morgan CJ;Pomat W;Crabb BS;Beeson JG;
{Journal}: Med
{Volume}: 0
{Issue}: 0
{Year}: 2024 Jun 4
暂无{DOI}: 10.1016/j.medj.2024.05.007
{Abstract}: <B>BACKGROUND: </B>Mycoplasma genitalium infection in pregnancy is increasingly reported at similar frequencies to other sexually transmitted infections (STIs). Knowledge on its contribution to adverse pregnancy outcomes is very limited, especially relative to other STIs or bacterial vaginosis (BV). Whether M. genitalium influences birthweight remains unanswered.<BR><B>METHODS: </B>Associations between birthweight and M. genitalium and other STIs (Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis) and BV in pregnancy were examined in 416 maternal-newborn pairs from a prospective cohort study in Papua New Guinea.<BR><B>RESULTS: </B>Compared to uninfected women, M. genitalium (-166.9 g, 95% confidence interval [CI]: -324.2 to -9.7 g, p = 0.038) and N. gonorrhoeae (-274.7 g, 95% CI: -561.9 to 12.5 g, p = 0.061) infections were associated with lower birthweight in an adjusted analysis. The association for C. trachomatis was less clear, and T. vaginalis and BV were not associated with lower birthweight. STI prevalence was high for M. genitalium (13.9%), N. gonorrhoeae (5.0%), and C. trachomatis (20.0%); co-infections were frequent. Larger effect sizes on birthweight occurred with co-infections of M. genitalium, N. gonorrhoeae, and/or C. trachomatis.<BR><B>CONCLUSIONS: </B>M. genitalium is a potential contributor to lower birthweight, and co-infections appear to have a greater negative impact on birthweight. Trials examining the impact of early diagnosis and treatment of M. genitalium and other STIs in pregnancy and preconception are urgently needed.<BR><B>BACKGROUND: </B>Funding was received from philanthropic grants, the National Health and Medical Research Council, and the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.